Onspira Therapeutics

Share on: 
Business Area(s): 
Description: 

ONSPIRA THERAPEUTICS is developing an inhaled interleukin-1 beta (IL-1β) receptor antagonist protein for the treatment of bronchiolitis obliterans syndrome (BOS) in post-lung transplant patients.

Location(s): 
Wayne PA
United States